SST2 as a marker of severely reduced exercise capacity in heart failure with reduced ejection fraction

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Magdalena Dudek

Poznan University of Medical Sciences, Poznan (Poland)

3 More presentations in this session

Presentation thumbnail

Correlation between aerobic functional capacity assessed by the one-minute sit-to-stand test and cardiopulmonary exercise testing in patients with heart failure with reduced ejection fraction

Associate Professor M. Remigio De Aguiar (Recife, BR) Associate Professor D. Brandao (Recife, BR)

Abstract Slides Video

Presentation thumbnail

Association of ECG abnormalities with heart failure exacerbation in HFimpEF: a multi-center retrospective analysis

Mr T. Sasaki (Morioka, JP)

Abstract Slides Video

Presentation thumbnail

Altered fibrin clot properties in patients with decompensated heart failure with reduced ejection fraction and sinus rhythm: an association with biventricular dysfunction.

Doctor K. Nowak (Krakow, PL)

Abstract Slides Video

Access the full session

Session thumbnail

Heart failure with reduced ejection fraction (HFrEF) (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Correlation of sST2 with chosen biochemical parameters and influence on prognosis in patients hospitalized due to HFrEF.

Congress Presentation

The optimal cut-off threshold of soluble suppressor of tumorigenicity 2 for prognostication in acute decompensated heart failure

Congress Presentation

Association of soluble ST2 with heart failure and other comorbidities in patients with severe coronary heart disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources